Feasibility Study of Cryotherapy for Chronic Venous Disorders

This study has been completed.
Sponsor:
Information provided by:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00617825
First received: February 6, 2008
Last updated: August 4, 2011
Last verified: September 2007
  Purpose

Severe skin damage caused by chronic venous disorders (CVDs) results in relentless pain and poor quality of life for millions of adults in the U.S. each year. DVDs are under-recognized and under-treated disorders shat harm the veins of the legs and at worst, cause skin inflammation and venous leg ulcers. A new way to ease the pain and inflammation is proposed in this study of cryotherapy (cool gel wraps) applied to damaged skin of the lower legs of CVD-affected individuals. The study hypothesis predicts that this novel cryotherapy model and method will significantly improve the health and quality of life for those with CVDs and that the intervention will become a standard of care for CVDs. In addition, the method will, over time, reduce health care costs associated with treating poor CVD outcomes.


Condition Intervention
Venous Insufficiency
Other: cyrotherapy as a cool gel wrap

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Cryotherapy for Chronic Venous Disorders

Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • improvement of skin microcirculation [ Time Frame: 30 days ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • leg pain [ Time Frame: 30 days ] [ Designated as safety issue: No ]
  • quality of life [ Time Frame: 30 days ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: September 2007
Study Completion Date: August 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: cyrotherapy as a cool gel wrap
    A cool gel wrap made of a hydrogel with silicon will be applied to the lower leg of skin affected by venous disorders for 30 minutes each day for 30 days during the study
    Other Name: Elastogel Therapy Wrap
Detailed Description:

Chronic venous disorders (CVDs) often cause long-term disability for those who experience the worst manifestations of CVDs: disabling pain and non-healing leg ulcers. Such disabilities have significant socioeconomic implications in terms of lost work days and wages, decreased productivity,and ultimately increased health care costs that deteriorate the well-being and quality of life for those who have CVD-induced illnesses. Because no reliable preventive mechanisms exists for CVDs, this study proposes a preventive, self-management cryotherapy intervention that targets inflamed skin of populations with CVDs at highest risk of developing chronic leg ulcers. The proposed cryotherapy intervention will utilize a randomized controlled clinical trial to develop a method to reduce clinical symptoms by improving existing therapy - it is not a treatment for CVDs itself. In the proposed pilot feasibility study, subjects will be randomized to two groups; the cryotherapy intervention group (n=30) who will receive a four-week, cryotherapy gel wrap applied daily to the affected skin of the lower legs in addition to the standard of care (usual care). The control group (n=30) will receive the usual care of compression wraps or stockings applied to the lower legs and daily leg elevation. With this method, improvement of skin microcirculation, reduced leg pain, and improvement in quality of life will be observed. The following aims will test the hypothesis:

Aim 1: Evaluate the feasibility of the novel intervention including treatment fidelity, subject training, safety, and side effects associated with equipment and recruitment efforts and further refine the intervention protocol, including questionnaires used in our previous studies.

Aim 2: Estimate variability of outcome measurements and effect sizes needed to calculate sample size for a subsequent larger, adequately powered, randomized clinical trial of the efficacy of the novel cryotherapy intervention.

Aim 3: Investigate the presence of a preliminary "signal" of clinical efficacy of the experimental treatment by evaluating trends toward statistical significance for the hypothesis that the experimental group will experience greater reduction in skin temperature and blood flow, greater improvement in pain, and greater improvement in quality of life.

  Eligibility

Ages Eligible for Study:   45 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Aged 45 years and older
  • CEAP classification: stage C4 (changes in skin and subcutaneous tissue secondary to CVDs)4a (pigmentation or eczema) 4b (lipodermatosclerosis or atrophie blanche) C5 (healed venous ulcers)
  • Ankle brachial index (ABI) 0.9 - 1.3mm Hg 0 absence of peripheral arterial disease
  • Intact skin sensation measured with 10 gram monofilament
  • Intact thermal sensation measured with thermal sensory tester at lower leg skin and foot surfaces
  • Agreement to wear compression garments such as wraps or stockings during waking hours
  • Phone, e-mail, or mail accessible
  • Working freezer

Exclusion Criteria:

  • ABI < 0.8 mm Hg or > 1.3 mm Hg -presence of lower extremity arterial disease (reduces skin temperature)
  • Active systemic or localized infections such as cellulitis (raises skin temperature)
  • Autoimmune disorders that reduce blood flow such as Raynaud's phenomenon
  • Body temperature > 37.6 degrees C (febrile state raises skin temperature)
  • CEAP classification c6: active venous ulcer (cooling ulcerated skin might impair healing)
  • Known peroneal nerve injury
  • Impaired skin sensation
  • Unable to detect light touch measured with a 10 gram monofilament at lower leg skin surfaces
  • Unable to detect not/cold sensation measured with thermal sensory tester at lower leg skin surfaces
  • Not wearing compression or not agreeing to wear compression wraps or stockings
  • Phone, e-mail, or mail inaccessible
  • No working freezer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00617825

Locations
United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425-1600
Sponsors and Collaborators
Medical University of South Carolina
Investigators
Principal Investigator: Teresa J Kelechi, PhD, RN Medical University of South Carolina
  More Information

No publications provided

Responsible Party: Teresa J. Kelechi, PhD, RN, Medical University of South Carolina
ClinicalTrials.gov Identifier: NCT00617825     History of Changes
Other Study ID Numbers: 17504, 1R21 NR010604-01
Study First Received: February 6, 2008
Last Updated: August 4, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Medical University of South Carolina:
chronic venous disorders
cryotherapy
skin microcirculation
skin temperature

Additional relevant MeSH terms:
Venous Insufficiency
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 28, 2014